Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2

AIM: To confirm the changes in proteins related with hypoxia-induced retinal cell death and to assess the effects of resveratrol (Res). METHODS: The therapeutic effect of Res was verified using an ischemic/reperfusion (I/R) model in vivo and a hypoxia modelin retinal ganglion cells (RGCs) in vitro....

Full description

Bibliographic Details
Main Authors: Hyemin Seong, Joo Yeon Jeong, Jinhyun Ryu, Juyeong Park, Yong-Seop Han, Hyun-Kyung Cho, Seong Jae Kim, Jong Moon Park, Sang Soo Kang, Seong Wook Seo
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2022-03-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://ies.ijo.cn/en_publish/2022/3/20220304.pdf
_version_ 1819349507606839296
author Hyemin Seong
Joo Yeon Jeong
Jinhyun Ryu
Juyeong Park
Yong-Seop Han
Hyun-Kyung Cho
Seong Jae Kim
Jong Moon Park
Sang Soo Kang
Seong Wook Seo
author_facet Hyemin Seong
Joo Yeon Jeong
Jinhyun Ryu
Juyeong Park
Yong-Seop Han
Hyun-Kyung Cho
Seong Jae Kim
Jong Moon Park
Sang Soo Kang
Seong Wook Seo
author_sort Hyemin Seong
collection DOAJ
description AIM: To confirm the changes in proteins related with hypoxia-induced retinal cell death and to assess the effects of resveratrol (Res). METHODS: The therapeutic effect of Res was verified using an ischemic/reperfusion (I/R) model in vivo and a hypoxia modelin retinal ganglion cells (RGCs) in vitro. Death of RGCs were confirmed by TUNEL assay. Protein expression was confirmed by Western blotting and immunohistochemistry. In addition, flow cytometric analysis was used to confirm the response in the cell unit to obtain more accurate data. RESULTS: ErbB2 expression and apoptosis in the ganglion cell layer (GCL) increased after I/R injury. Treatment of Res rescued I/R-induced ganglion cell death, downregulated apoptosis and ErbB2 protein expression in the retina. In subsequent in vitro models, Res affects apoptosis by regulating the phosphorylation and expression of mouse double minute 2 homolog (MDM2), along with those of ErbB2. These results suggest that Res reverses GCL-specific apoptosis via downregulation of ErbB2 in ischemic injury. CONCLUSION: In light of Res favorable properties, it should be evaluated in the treatment of RGC death and related retinal disease characterized by ErbB2 and MDM2 expression. Therefore, Res is appropriate therapeutic agent for treating ischemic injury-related eye diseases by targeting the expression of ErbB2 and MDM2.
first_indexed 2024-12-24T19:01:37Z
format Article
id doaj.art-2f0018cd21f64ed0a74436aa96638615
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-12-24T19:01:37Z
publishDate 2022-03-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-2f0018cd21f64ed0a74436aa966386152022-12-21T16:43:11ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982022-03-0115339440010.18240/ijo.2022.03.0420220304Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2Hyemin Seong0Joo Yeon Jeong1Jinhyun Ryu2Juyeong Park3Yong-Seop Han4Hyun-Kyung Cho5Seong Jae Kim6Jong Moon Park7Sang Soo Kang8Seong Wook Seo9Seong Wook Seo. Department of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, 15 Jinju-daero 816 Beon-gil, Jinju, Gyeongnam 52727, Republic of Korea. stramast@naver.com; Sang Soo Kang. Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, 15 Jinju-daero 816 Beon-gil, Jinju, Gyeongnam 52727, Republic of Korea. kangss@gnu.ac.krDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Gyeongsang National University Changwon Hospital, Gyeongsang National University, College of Medicine, Changwon 51472, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaDepartment of Ophthalmology, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Republic of KoreaAIM: To confirm the changes in proteins related with hypoxia-induced retinal cell death and to assess the effects of resveratrol (Res). METHODS: The therapeutic effect of Res was verified using an ischemic/reperfusion (I/R) model in vivo and a hypoxia modelin retinal ganglion cells (RGCs) in vitro. Death of RGCs were confirmed by TUNEL assay. Protein expression was confirmed by Western blotting and immunohistochemistry. In addition, flow cytometric analysis was used to confirm the response in the cell unit to obtain more accurate data. RESULTS: ErbB2 expression and apoptosis in the ganglion cell layer (GCL) increased after I/R injury. Treatment of Res rescued I/R-induced ganglion cell death, downregulated apoptosis and ErbB2 protein expression in the retina. In subsequent in vitro models, Res affects apoptosis by regulating the phosphorylation and expression of mouse double minute 2 homolog (MDM2), along with those of ErbB2. These results suggest that Res reverses GCL-specific apoptosis via downregulation of ErbB2 in ischemic injury. CONCLUSION: In light of Res favorable properties, it should be evaluated in the treatment of RGC death and related retinal disease characterized by ErbB2 and MDM2 expression. Therefore, Res is appropriate therapeutic agent for treating ischemic injury-related eye diseases by targeting the expression of ErbB2 and MDM2.http://ies.ijo.cn/en_publish/2022/3/20220304.pdfischemia/reperfusion injuryhypoxiaretinal ganglion cellresveratrolerbb2
spellingShingle Hyemin Seong
Joo Yeon Jeong
Jinhyun Ryu
Juyeong Park
Yong-Seop Han
Hyun-Kyung Cho
Seong Jae Kim
Jong Moon Park
Sang Soo Kang
Seong Wook Seo
Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
International Journal of Ophthalmology
ischemia/reperfusion injury
hypoxia
retinal ganglion cell
resveratrol
erbb2
title Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
title_full Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
title_fullStr Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
title_full_unstemmed Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
title_short Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2
title_sort resveratrol prevents hypoxia induced retinal ganglion cell death related with erbb2
topic ischemia/reperfusion injury
hypoxia
retinal ganglion cell
resveratrol
erbb2
url http://ies.ijo.cn/en_publish/2022/3/20220304.pdf
work_keys_str_mv AT hyeminseong resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT jooyeonjeong resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT jinhyunryu resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT juyeongpark resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT yongseophan resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT hyunkyungcho resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT seongjaekim resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT jongmoonpark resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT sangsookang resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2
AT seongwookseo resveratrolpreventshypoxiainducedretinalganglioncelldeathrelatedwitherbb2